Tags · Sourcing
mislabelling
Wrong compound, wrong strength, or wrong batch on the label.
Related in this group: certificate of analysis · batch & lot numbers · Janoshik Analytical · Medutest · PeptideMeter · VendorInvestigate · third-party testing · blind sampling · documentation quality · underdosing · customs · shipping
41 topics · page 1 of 2
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A supplier who responds to a discrepancy with silence — what changed since
A supplier who responds to a discrepancy with silence — what changed since — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better…
|
+83 | 88 | 21k | 6h |
|
Compounds this community declines to help with, and why — does this still hold?
Compounds this community declines to help with, and why — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SCALE ( N Engl J Med ,…
|
+3 | 7 | 26k | 7h |
|
AOD-9604 and the fragment hypothesis, revisited — does this still hold?
The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it. Comparing FLOW ( N Engl J Med , 2024)…
|
+7 | 11 | 31k | 19h |
|
Coming back to: When a red flag was a misunderstanding, and the retraction
When a red flag was a misunderstanding, and the retraction I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the answers here are usually…
|
+6 | 10 | 257 | 21h |
|
Research-use-only status: what it means legally and practically
Research-use-only status: what it means legally and practically Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited in…
|
+72 | 81 | 44k | 1d |
|
Batch numbers that do not match the vial label
Batch numbers that do not match the vial label — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately from product…
|
+43 | 48 | 8.9k | 2d |
|
Naming conventions for research peptides and the confusion they cause
Posting this under the heading it deserves: Naming conventions for research peptides and the confusion they cause Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with STEP 1 ( N…
|
+21 | 25 | 4.9k | 22d |
|
Batch numbers that do not match the vial label — what changed since
On the subject in the title: Batch numbers that do not match the vial label — what changed since Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+39 | 43 | 14k | 1mo |
|
A certificate whose chromatogram axes do not match its stated method — one year on
A certificate whose chromatogram axes do not match its stated method — one year on Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion,…
|
+103 | 111 | 8.1k | 2mo |
|
Revisiting: Patterns that reliably precede a problem, documented
Posting this under the heading it deserves: Revisiting: Patterns that reliably precede a problem, documented Everything below is what sits behind that. A logistics question, since the answers here are usually…
|
+16 | 20 | 36k | 2mo |
|
Second pass at: Identical chromatograms across two different lots
Posting this under the heading it deserves: Second pass at: Identical chromatograms across two different lots Everything below is what sits behind that. A logistics question, since the answers here are…
|
+81 | 93 | 13k | 4mo |
|
Coming back to: Reading a supplier's product description as a marketing document
Reading a supplier's product description as a marketing document Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in…
|
+35 | 39 | 688 | 5mo |
|
Distinguishing a red flag from an inconvenience
Distinguishing a red flag from an inconvenience — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately from product…
|
2 | 38k | 6mo | |
|
Follow-up: A supplier that answers analytical questions with restated claims
A supplier that answers analytical questions with restated claims — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than…
|
+74 | 82 | 2.8k | 6mo |
|
AOD-9604 and the fragment hypothesis, revisited
Posting this under the heading it deserves: AOD-9604 and the fragment hypothesis, revisited Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with SUSTAIN 6 ( N Engl J Med…
|
+40 | 44 | 2.8k | 6mo |
|
Documentation that appears only after payment
Documentation that appears only after payment Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal, separately from…
|
+113 | 124 | 13k | 7mo |
|
Pricing far outside the range, in either direction
Posting this under the heading it deserves: Pricing far outside the range, in either direction Everything below is what sits behind that. Structured report rather than an opinion, following the format the…
|
+3 | 7 | 27k | 7mo |
|
Sequence verification for an obscure compound: how it is done — what changed since
On the subject in the title: Sequence verification for an obscure compound: how it is done — what changed since Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please…
|
+100 | 108 | 1.3k | 8mo |
|
Reading a supplier's product description as a marketing document
On the subject in the title: Reading a supplier's product description as a marketing document Working notes rather than a conclusion. I have seen PIONEER 6 ( N Engl J Med , 2019) cited in support of a claim I…
|
+86 | 97 | 62k | 8mo |
|
Research-use-only status: what it means legally and practically — does this still hold?
Asking directly, because I could not find a straight answer: Research-use-only status: what it means legally and practically — does this still hold? Session topic: SELECT ( N Engl J Med , 2023). Please read…
|
2 | 309 | 9mo | |
|
Compounds this community declines to help with, and why
Compounds this community declines to help with, and why — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SCALE ( N Engl J Med , 2015) and…
|
+81 | 87 | 35k | 10mo |
|
Why catalogue breadth is not evidence of anything — what changed since
Asking directly, because I could not find a straight answer: Why catalogue breadth is not evidence of anything — what changed since Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
+62 | 66 | 26k | 10mo |
|
How to research a compound with no human data without deceiving yourself
Asking directly, because I could not find a straight answer: How to research a compound with no human data without deceiving yourself Session topic: STEP 2 ( Lancet , 2021). Please read it before posting; the…
|
+107 | 119 | 11k | 12mo |
|
Sequence verification for an obscure compound: how it is done
Sequence verification for an obscure compound: how it is done Writing it up because I had to work it out twice and would rather nobody else did. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with SURMOUNT-1 ( N…
|
+104 | 114 | 10k | 12mo |
|
Follow-up: Why we hide unevidenced fraud accusations and log the hiding
The question in the title: Why we hide unevidenced fraud accusations and log the hiding I will give what I have already checked below so nobody repeats it. Structured report rather than an opinion, following…
|
+12 | 16 | 17k | 12mo |
|
A supplier that answers analytical questions with restated claims
On the subject in the title: A supplier that answers analytical questions with restated claims Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+107 | 118 | 45k | 12mo |
|
Second pass at: How to research a compound with no human data without deceiving yourself
Second pass at: How to research a compound with no human data without deceiving yourself Writing it up because I had to work it out twice and would rather nobody else did. Comparing STEP 1 ( N Engl J Med ,…
|
+64 | 71 | 2.5k | 13mo |
|
A certificate whose chromatogram axes do not match its stated method
Posting this under the heading it deserves: A certificate whose chromatogram axes do not match its stated method Everything below is what sits behind that. Structured report rather than an opinion, following…
|
+9 | 13 | 182 | 13mo |
|
Why we hide unevidenced fraud accusations and log the hiding
Why we hide unevidenced fraud accusations and log the hiding — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to talk about documentation quality as a…
|
+97 | 106 | 63k | 14mo |
|
Follow-up: Documentation that appears only after payment
Posting this under the heading it deserves: Documentation that appears only after payment Everything below is what sits behind that. I would like to talk about documentation quality as a signal, separately…
|
+82 | 87 | 50k | 14mo |
Sponsored
Janoshik Analytical — independent third-party testingHPLC purity and mass-spectrometric identity on submitted samples, reported with the method stated. The laboratory most often cited in this community’s verification records.Independent testing →
Sponsored
GL Biochem (Shanghai) Ltd. — synthesis, directFounded 1998. ISO 9001 and cGMP certified, over 1,500 staff and 200-plus patents. Custom peptide synthesis and amino acid derivatives, with a batch certificate on every order.Custom synthesis →